DIFFUSE INTRINSIC PONTINE GLIOMA
Clinical trials for DIFFUSE INTRINSIC PONTINE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE INTRINSIC PONTINE GLIOMA trials appear
Sign up with your email to follow new studies for DIFFUSE INTRINSIC PONTINE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Electric cap tested in fight against Kids' brain cancer
Disease control OngoingThis trial is testing a wearable medical device called Optune for children with aggressive brain tumors. The device uses low-intensity electric fields to try to slow or stop tumor growth. The study has two parts: one for kids whose tumors have come back, and another for kids newl…
Matched conditions: DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: NA • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for kids with devastating brain cancer: first safety trial of experimental drug
Disease control OngoingThis study is testing the safety of a new oral drug called PTC596 (Unesbulin) when given alongside standard radiation therapy to children and young adults newly diagnosed with aggressive brain tumors, including a very hard-to-treat type called DIPG. The main goals are to find the…
Matched conditions: DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE1 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New vaccine trial aims to train Kids' immune systems to fight deadly brain cancers
Disease control OngoingThis study is testing a cancer vaccine called SurVaxM in children and young adults with aggressive brain tumors that have come back or progressed. The vaccine is designed to teach the body's immune system to find and destroy cancer cells that carry a specific protein called survi…
Matched conditions: DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE1 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for kids with deadly brain tumors: experimental therapy targets cancer directly in the brain
Disease control OngoingThis early-stage study is testing a new type of personalized immune cell therapy called SC-CAR4BRAIN for children and young adults with aggressive brain tumors that have come back or not responded to standard treatments. Doctors collect a patient's own immune cells, modify them i…
Matched conditions: DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New hope for kids with tough cancers: trial tests personalized immune cell treatment
Disease control OngoingThis early-stage study is testing a new, personalized treatment for children with two aggressive cancers: recurrent neuroblastoma or a newly diagnosed brain stem tumor called DIPG. Doctors create a custom treatment using the patient's own immune cells and tumor material, aiming t…
Matched conditions: DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE1 • Sponsor: University of Florida • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
Experimental treatment tested for deadly childhood brain cancer
Disease control TerminatedThis study is testing whether Antineoplaston therapy can help control DIPG, a rare and aggressive brainstem tumor that currently has very limited treatment options. The trial is designed for children and adults with DIPG, including those who have tried standard treatments and tho…
Matched conditions: DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE2 • Sponsor: Burzynski Research Institute • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
New hope for kids with tough brain cancers: trial tests Immune-Boosting drug
Disease control OngoingThis study is testing whether adding an immunotherapy drug called indoximod to standard chemotherapy and radiation can better control aggressive brain tumors in children and young adults. It is for patients aged 3 to 21 with certain progressive brain cancers or a newly diagnosed,…
Matched conditions: DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE2 • Sponsor: Theodore S. Johnson • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC